SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-15-286583
Filing Date
2015-08-11
Accepted
2015-08-11 17:15:12
Documents
9
Period of Report
2015-08-11

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d23993d6k.htm 6-K 10994
2 EX-99.1 d23993dex991.htm EX-99.1 330036
3 EX-99.2 d23993dex992.htm EX-99.2 168400
4 EX-99.3 d23993dex993.htm EX-99.3 9537
5 EX-99.4 d23993dex994.htm EX-99.4 9544
6 GRAPHIC g23993g44m38.jpg GRAPHIC 155031
7 GRAPHIC g23993g80n92.jpg GRAPHIC 21177
8 GRAPHIC g23993g85k78.jpg GRAPHIC 15812
9 GRAPHIC g23993g95o94.jpg GRAPHIC 142735
  Complete submission text file 0001193125-15-286583.txt   990711
Mailing Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8
Business Address #1203-4464 MARKHAM STREET VICTORIA BC A1 V8Z 7X8 250-708-4272
Aurinia Pharmaceuticals Inc. (Filer) CIK: 0001600620 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-36421 | Film No.: 151044745
SIC: 2834 Pharmaceutical Preparations